Literature DB >> 29407993

Synthesis of coumarin-theophylline hybrids as a new class of anti-tubercular and anti-microbial agents.

Sumitra N Mangasuli1, Kallappa M Hosamani2, Hirihalli C Devarajegowda3, Mahantesh M Kurjogi4, Shrinivas D Joshi5.   

Abstract

A series of novel coumarin-theophylline hybrids were synthesized and examined for their anti-tubercular activity in vitro against Mycobacterium tuberculosis H37Rv, anti-microbial activity in vitro against gram-positive bacteria (Staphylococcus aureus) and gram-negative bacterias (Escherichia coli, Salmonella typhi) as well as fungi (Candida albicans). The compound (3a) has shown excellent anti-tubercular activity with MIC of 0.12 μg/mL. Electron donating compounds (3a, 3f) have displayed significant anti-microbial activity. The compounds have also been precisely elucidated using single crystal X-ray diffraction techniques. Molecular docking study has been performed against 4DQU enzyme of Mycobacterium tuberculosis showed good binding interactions and is in agreement with the in vitro results.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Anti-microbial; Anti-tuberculosis; Coumarin-theophylline hybrids; Molecular docking; X-ray structure

Mesh:

Substances:

Year:  2018        PMID: 29407993     DOI: 10.1016/j.ejmech.2018.01.025

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

Review 1.  Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus.

Authors:  Adetomiwa A Adeniji; Kirsten E Knoll; Du Toit Loots
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-05       Impact factor: 4.813

Review 2.  Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids.

Authors:  Harbinder Singh; Jatinder Vir Singh; Kavita Bhagat; Harmandeep Kaur Gulati; Mohit Sanduja; Nitish Kumar; Nihar Kinarivala; Sahil Sharma
Journal:  Bioorg Med Chem       Date:  2019-06-22       Impact factor: 3.641

Review 3.  Molecular Insights into Coumarin Analogues as Antimicrobial Agents: Recent Developments in Drug Discovery.

Authors:  Rameshwar S Cheke; Harun M Patel; Vaishali M Patil; Iqrar Ahmad Ansari; Jaya P Ambhore; Sachin D Shinde; Adel Kadri; Mejdi Snoussi; Mohd Adnan; Prashant S Kharkar; Visweswara Rao Pasupuleti; Prashant K Deshmukh
Journal:  Antibiotics (Basel)       Date:  2022-04-24

4.  Discovery of a Novel Inhibitor Structure of Mycobacterium tuberculosis Isocitrate Lyase.

Authors:  Changyuan Duan; Qihua Jiang; Xue Jiang; Hongwei Zeng; Qiaomin Wu; Yang Yu; Xiaolan Yang
Journal:  Molecules       Date:  2022-04-11       Impact factor: 4.927

5.  Synthesis of Coumarin Derivatives: A New Class of Coumarin-Based G Protein-Coupled Receptor Activators and Inhibitors.

Authors:  Zhe Fu; Linjie Zhang; Sijin Hang; Shiyi Wang; Na Li; Xiaojing Sun; Zian Wang; Ruilong Sheng; Fang Wang; Wenhui Wu; Ruihua Guo
Journal:  Polymers (Basel)       Date:  2022-05-15       Impact factor: 4.967

6.  Synthesis, Hemolytic Studies, and In Silico Modeling of Novel Acefylline-1,2,4-Triazole Hybrids as Potential Anti-cancer Agents against MCF-7 and A549.

Authors:  Irum Shahzadi; Ameer Fawad Zahoor; Azhar Rasul; Asim Mansha; Sajjad Ahmad; Zohaib Raza
Journal:  ACS Omega       Date:  2021-04-30

7.  Microwave assisted synthesis of coumarin-purine derivatives: An approach to in vitro anti-oxidant, DNA cleavage, crystal structure, DFT studies and Hirshfeld surface analysis.

Authors:  Sumitra N Mangasuli; Kallappa M Hosamani; Praveen B Managutti
Journal:  Heliyon       Date:  2019-01-21

Review 8.  Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis.

Authors:  Saad Alghamdi; Shaheed Ur Rehman; Nashwa Talaat Shesha; Hani Faidah; Muhammad Khurram; Sabi Ur Rehman
Journal:  Molecules       Date:  2020-12-02       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.